Radiomics and radiogenomics in neuro-oncology an artificial intelligence paradigm. Volume 1, Radiogenomics Flow Using Artificial Intelligence /
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
[S.l.] :
Academic press,
2024.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Intro
- Radiomics and Radiogenomics in Neuro-Oncology
- Copyright
- Contents
- Contributors
- About the editors
- Preface
- Acknowledgments
- Section 1: Introduction
- Chapter 1: Fundamentals pipelines of radiomics and radiogenomics (R-n-R)
- 1.1. Introduction
- 1.2. Pipeline of radiomics
- 1.2.1. Image acquisition
- 1.2.2. Image preprocessing
- 1.2.3. Tumor detection and segmentation using region of interest (ROI)
- 1.2.4. Conventional or deep learning-based feature extraction
- 1.2.5. Feature selection
- 1.2.6. Predictive models
- 1.2.6.1. Statistical analysis
- 1.2.6.2. Machine learning
- 1.2.6.3. Deep learning
- 1.2.7. Evaluation and diagnosis
- 1.3. Pipeline of radiogenomics
- 1.3.1. Tissue extraction and gene sequence
- 1.3.2. Data preprocessing
- 1.3.3. Association of radiomics and genomics
- 1.3.4. Correlation analysis and prediction
- 1.3.5. Outcomes
- 1.4. Discussion and conclusion
- References
- Chapter 2: Artificial intelligence, its components, and crucial technologies for its implementation
- 2.1. Introduction
- 2.1.1. Examples of AI usage in the medical domain
- 2.2. Advances in disease management with AI algorithms
- 2.3. State-of-the-art algorithms
- 2.4. Challenges in AI implementation for medical imaging
- 2.5. Strategies for overcoming hurdles to implementing AI in disease management
- 2.6. Recent scope of developments for AI in medicine
- 2.7. AI beyond classical learning
- 2.8. Challenges of AI for the future
- 2.9. Conclusion
- 2.10. Final say
- References
- Chapter 3: Radiomics and radiogenomics with artificial intelligence: Approaches, applications, advances, current challeng ...
- 3.1. Introduction
- 3.2. Overview of radiomics and radiogenomics
- 3.3. Radiogenomics
- 3.3.1. Neurooncology
- 3.3.2. Coronary heart disease
- 3.3.3. Cancer liver metastases (CRLM)
- 3.3.4. Diagnosis of lung cancer
- 3.3.5. Brain
- 3.3.6. Prostate
- 3.3.7. The application of radiomics in breast MRI
- 3.4. Artificial intelligence
- 3.4.1. Deep learning
- 3.4.2. Deep learning architectures in radiomics
- 3.5. Discussion
- 3.6. Conclusion
- References
- Section 2: Genomics and molecular study of brain cancer
- Chapter 4: Brain cancer and World Health Organization
- 4.1. Introduction
- 4.2. Brain cancer and its types
- 4.2.1. Gliomas
- 4.2.2. Medulloblastoma
- 4.2.3. Meningiomas
- 4.2.4. Ependymoma
- 4.3. WHO perspectives on brain cancer
- 4.3.1. CNS WHO grading and examples
- 4.3.2. Switching to Arabic numerals from Roman numerals for the grading system
- 4.3.3. Grading within types
- 4.3.4. Introduction of new entities
- 4.3.5. Diagnostic and therapeutic implications
- 4.4. Biology of brain cancer
- 4.4.1. Genetic mutations
- 4.4.2. Epigenetic changes
- 4.4.3. Aberrant cell signaling
- 4.4.4. Tumor microenvironment
- 4.4.5. Immunosuppression
- 4.5. Challenges to cure brain cancer
- 4.5.1. Multifaceted tumor characteristics